Effects of a physician office generic drug sampling system on generic dispensing ratios and drug costs in a large managed care organization

Journal of Managed Care Pharmacy

Volumn 13, Issue 5, 2007, Pages 412-419

  Scott, Amy B ^a   Culley, Eric J ^a   O'Donnell, Jerry ^a  

^a Highmark Blue Cross Blue Shield   (United States)

Author keywords

Automated sampling; Generic dispensing ratio; Generic sampling; Physician detailing; Prescribing patterns; Return on investment

Indexed keywords

AMOXICILLIN; ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; ANTIINFECTIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CEFALEXIN; CITALOPRAM; COTRIMOXAZOLE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOXYCYCLINE HYCLATE; ERYTHROMYCIN; FLUOXETINE; FUROSEMIDE; GENERIC DRUG; GLIPIZIDE; HYDROCHLOROTHIAZIDE; HYDROCHLOROTHIAZIDE PLUS TRIAMTERENE; IBUPROFEN; LISINOPRIL; METFORMIN; METOPROLOL TARTRATE; MEVINOLIN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLIN V POTASSIUM; RANITIDINE; SEROTONIN UPTAKE INHIBITOR; TRIAMCINOLONE ACETATE; UNINDEXED DRUG;

ARTICLE; AUTOMATION; CHRONIC DISEASE; COMPUTER PROGRAM; COST CONTROL; DRUG COST; DRUG UTILIZATION; GENERAL PRACTITIONER; HUMAN; HYPERTENSION; MANAGED CARE ORGANIZATION; MEDICAL PRACTICE; PRESCRIPTION; PRIMARY MEDICAL CARE; REIMBURSEMENT; SAMPLING;

EID: 34547480825     PISSN: 10834087     EISSN: None     Source Type: Journal    
DOI: 10.18553/jmcp.2007.13.5.412     Document Type: Article

References (13)

1. Kaiser Family Foundation. Prescription drug trends fact sheet - June 2006 update. Available at: www.kff.org/rxdrugs/upload/3057-05.pff. Accessed May 27, 2007.
2. Tseng CW, Brook RH, Keeler E, Steers WN, Waizfelder BE, Mangione CM. Effect of generic-only drug benefits on seniors' medication use and financial burden. Am J Manag Care. 2006;12:525-32.
3. Gibson TB, Ozminkowski RJ, Goetzel RZ: The effects of prescription drug cost sharing: a review of the evidence. Am J Manag Care. 2005;11:730-40.
4. Taylor H, Leitman R, eds. Out-of-pocket costs are a substantial barrier to prescription drug compliance; as copayments increase over the next two years, noncompliance will probably get worse. Health Care News. 2001;1(32):1-2.
5. Meyer MC. Generic drug product equivalence: current status. Am J Manag Care. 1998;4:1183-89.
6. Kirking DM, Ascione FJ, Gaither CA, et al. Economics and structure of the generic pharmaceutical industry. J Am Pharm Assoc. 2001;41:578-84.
7. Cox E, Behm A, Mager D. Express Scripts, 2005 generic drug usage report; 2005. Available at: www.express-scripts.com/ourcompany/news/ outcomesresearch/onlinepublications/. Accessed September 15, 2006.
8. Shrank WH, Asch SM, Joseph GJ, et al. Physicians' perceived knowledge of and responsibility for managing patients' out-of-pocket costs for prescription drugs. Ann Pharmacother. 2006;40:1534-40.
9. Ross SM, Papshev D, Murphy EL, Stemberg DJ, Taylor J, Barg R. Effects of electronic prescribing on formulary compliance and generic drug utilization in the ambulatory care setting: a retrospective analysis of administrative claims data. J Manag Care Pharm. 2005; 11(5):410-15. Available at http://www.amcp.org/data/jmcp/ contemporary_410-415.pdf. Accessed May 27, 2007.
10. Combating generics: pharmaceutical brand defense for 2007 (PH76). Available at: www.cuttingedgeinfo.com/pharmagenerics. Accessed September 15, 2006.
11. Hennekens C, Buring J, eds. Epidemiology in Medicine. Boston, MA: Little, Brown and Company; 1987.
12. O'Malley AJ, Frank RG, Kaddis A, Rothenberg BM, McNeil BJ. Impact of alternative interventions on changes in generic dispensing rates. Health Serv Res. 2006;41(5):1876-94.
13. Adair RF, Holmgren LR. Do drug samples influence resident prescribing behavior? A randomized trial. Am J Med. 2005; 118(8):881-84.